Pricing is transparent, with no hidden fees
Improved glycaemic control from Wegovy may actually reduce yeast infection risk over time in patients with diabetes
At Flow Wellness, we regularly reassure patients that these reactions are typically mild and resolve within a few hours to several days without treatment
Presented for research literature review only Oguchi M et al
The drug is known generically as liraglutide, which the FDA says has been in short supply with certain other GLP-1 medications. This references the consistent shortages for drugs like semaglutides, known by brand names such as Ozempic and Wegovy, and tirzepatides, with brand names like Zepbound and Mounjaro
Because of the growing popularity of these drugs, Congress or CMS may yet build something permanent